An Open-Label, Single and Multiple Oral Dose Pharmacokinetic Study of Vigabatrin in Infants With Infantile Spasms
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to evaluate vigabatrin pharmacokinetics (PK) in
neonates receiving vigabatrin for infantile spasms (IS); and to determine the safety of
vigabatrin.